These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 15450355)

  • 21. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
    Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
    Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
    Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF
    Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
    Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
    Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination.
    Coma M; Guix FX; Uribesalgo I; Espuña G; Solé M; Andreu D; Muñoz FJ
    Brain; 2005 Jul; 128(Pt 7):1613-21. PubMed ID: 15817516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aβ plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: a study in APP mutant mice.
    Luccarini I; Grossi C; Traini C; Fiorentini A; Ed Dami T; Casamenti F
    Neurosci Lett; 2012 Jan; 506(1):94-9. PubMed ID: 22056484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice.
    Doehner J; Madhusudan A; Konietzko U; Fritschy JM; Knuesel I
    J Alzheimers Dis; 2010; 19(4):1339-57. PubMed ID: 20061602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
    Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
    Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
    J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques.
    Steinhoff T; Moritz E; Wollmer MA; Mohajeri MH; Kins S; Nitsch RM
    Neurobiol Dis; 2001 Aug; 8(4):647-54. PubMed ID: 11493029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.
    Lazarov O; Robinson J; Tang YP; Hairston IS; Korade-Mirnics Z; Lee VM; Hersh LB; Sapolsky RM; Mirnics K; Sisodia SS
    Cell; 2005 Mar; 120(5):701-13. PubMed ID: 15766532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related accumulation of Reelin in amyloid-like deposits.
    Knuesel I; Nyffeler M; Mormède C; Muhia M; Meyer U; Pietropaolo S; Yee BK; Pryce CR; LaFerla FM; Marighetto A; Feldon J
    Neurobiol Aging; 2009 May; 30(5):697-716. PubMed ID: 17904250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations.
    Willis M; Hutter-Paier B; Wietzorrek G; Windisch M; Humpel C; Knaus HG; Marksteiner J
    Brain Res; 2007 Apr; 1143():199-207. PubMed ID: 17328871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
    Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
    J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain.
    Perez JL; Carrero I; Gonzalo P; Arevalo-Serrano J; Sanz-Anquela JM; Ortega J; Rodriguez M; Gonzalo-Ruiz A
    Exp Neurol; 2010 Jun; 223(2):410-21. PubMed ID: 19879263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.